Breaking News

Rentschler Biopharma Invests in New Media Station at Germany HQ

The four-story buffer media station, covering 34,000 square meters, is set to be operational by 2028.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), is constructing a new state-of-the-art buffer media station at its company headquarters in Laupheim. The new facility aims to further increase production efficiency and modernize the site.   The four-story buffer media station, covering 34,000 square meters, is set to be operational by 2028. The new facility will be integrated with the existing infrastructure to help offer fast...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters